Lupus doesn’t have a single cause. It develops when a combination of genetic vulnerability, hormonal influences, and environmental triggers pushes the immune system into attacking the body’s own tissues. About 9 out of 10 people diagnosed with lupus are women, and the highest risk group is women of childbearing age (15 to 44), which points to the powerful role that biology and hormones play alongside other factors.
Genetics Set the Stage
Lupus runs in families, but it’s not as simple as inheriting one faulty gene. Instead, dozens of genetic variations each contribute a small amount of risk. The most well-studied are found in a cluster of immune-related genes on chromosome 6 called the HLA region. Two specific gene variants, known as HLA-DR2 and HLA-DR3, increase susceptibility to lupus across multiple ethnic backgrounds. These variants appear to raise risk partly by lowering levels of a protein called C4, which normally helps the body clear away dead cells and cellular debris. When that cleanup system underperforms, leftover cell material can trigger an immune response against the body’s own tissues.
Having these gene variants doesn’t guarantee you’ll develop lupus. Most people who carry them never do. But when combined with the right environmental exposure or hormonal shift, the genetic groundwork can tip the balance toward disease.
Estrogen Fuels the Immune Response
The striking gender gap in lupus, roughly 184,000 women compared to 20,000 men in the U.S., strongly implicates estrogen. Lupus patients tend to have higher estrogen levels than healthy individuals, and those levels correlate with disease severity. Taking estrogen in the form of oral contraceptives or hormone replacement therapy can increase the risk of developing lupus in healthy women and worsen symptoms in those already diagnosed.
Estrogen influences the immune system in several ways. It affects how T cells function and how B cells produce antibodies. Research has shown that estrogen activates immune cells through receptors on the cell surface, promoting inflammation. In one mechanism, estrogen binds to a surface receptor on immune cells called GPER1, which ramps up the activation of monocytes (a type of white blood cell) and increases the production of inflammatory signals. This helps explain why lupus symptoms often flare during pregnancy, around menstrual cycles, and during other periods of hormonal change.
Sunlight and Skin Cell Damage
Ultraviolet light is one of the most consistent environmental triggers for lupus flares. When UV rays hit the skin, they cause skin cells to die through a process called apoptosis. In most people, those dead cells are quietly cleared away. In lupus, the cleanup process is impaired.
Within about 8 hours of UV exposure, dying skin cells push proteins from their interior to the surface, forming small bubble-like structures called blebs. These blebs are packed with molecules that the immune system of a lupus-prone person may recognize as foreign, triggering the production of autoantibodies. On top of that, skin cells from people with photosensitive lupus are significantly more vulnerable to UV damage than normal skin cells, creating a cycle where sun exposure causes more cell death, which releases more self-antigens, which fuels more immune attack.
Epigenetic Changes From the Environment
Beyond direct genetic inheritance, environmental exposures can change how your genes behave without altering the DNA sequence itself. These are called epigenetic changes, and one of the most important in lupus involves a process called DNA methylation. Methylation acts like a dimmer switch on genes. When certain immune genes lose their methylation, they get turned up too high, and immune cells become overactive and self-reactive.
In people with active lupus, a specific type of immune cell (CD4+ T cells) shows reduced DNA methylation. This change alone is powerful enough to convert normal immune cells into autoreactive, inflammatory cells capable of causing lupus-like disease in animal models. A wide range of environmental exposures can drive this process by creating oxidative stress, which damages the cellular machinery responsible for maintaining methylation. The list of known contributors includes UV light, cigarette smoke, infections, silica dust, heavy metals, pesticides, and air pollution. Even a diet low in certain nutrients needed for methylation (like folate and methionine) can contribute.
Viral Infections, Especially Epstein-Barr
Epstein-Barr virus (EBV), the virus that causes mono, has the strongest infectious link to lupus. Both children and adults with lupus carry antibodies to EBV at higher rates than the general population. More telling, EBV reactivation (when a dormant infection flares back up) has been associated with the transition from preclinical autoimmunity to full-blown lupus, and with increased disease activity in people already diagnosed.
The connection appears to involve the way EBV hijacks B cells, the immune cells responsible for making antibodies. Research published in Science Translational Medicine found that EBV reprograms certain self-reactive B cells in ways that promote the autoimmune process. Since roughly 95% of adults worldwide carry EBV, the virus alone isn’t enough to cause lupus. But in someone with the right genetic background, EBV infection may be the spark that sets the process in motion.
Smoking and Lupus Risk
Current smokers face a 50% higher risk of developing lupus compared to people who have never smoked. The risk is even more pronounced for a specific subtype: current smoking nearly doubles the likelihood of developing lupus characterized by anti-DNA antibodies (a hallmark of more severe disease). Interestingly, the elevated risk applies to current smokers but not to former smokers, suggesting the effect is tied to ongoing exposure.
Cigarette smoke drives lupus risk through multiple pathways. The reactive oxygen species produced during tobacco metabolism damage DNA, creating altered DNA structures that the immune system may treat as foreign, stimulating autoantibody production. Smoking also increases expression of a specific receptor on the surface of B cells and T cells that triggers cell death. When too many cells die at once, the body’s cleanup systems become overwhelmed, leaving behind the kind of cellular debris that feeds autoimmune reactions.
Occupational and Chemical Exposures
Crystalline silica, a fine dust produced during mining, sandblasting, construction, and certain manufacturing processes, has been identified as a potential lupus trigger. Silica appears to act as an immune adjuvant, meaning it nonspecifically amplifies the immune response and increases antibody production. Occupational cohort studies suggest that silica-exposed workers have higher rates of lupus, and exposed patients may be more likely to develop anti-DNA antibodies, one of the more damaging autoantibody types in the disease. Heavy metals like mercury can also contribute by depleting the body’s natural antioxidants, creating the same kind of oxidative stress that disrupts DNA methylation in immune cells.
Medications That Mimic Lupus
Certain prescription drugs can cause a lupus-like syndrome called drug-induced lupus. The symptoms, including joint pain, fever, and skin rashes, resemble those of systemic lupus but typically resolve within weeks to months after stopping the medication. The most commonly implicated drugs include hydralazine (used for high blood pressure), procainamide (used for irregular heartbeat), isoniazid (used for tuberculosis), minocycline (an antibiotic), and TNF-alpha inhibitors used for autoimmune conditions like rheumatoid arthritis.
The mechanism behind drug-induced lupus ties back to epigenetics. Procainamide directly blocks the enzyme responsible for DNA methylation, while hydralazine reduces the levels of that same enzyme. Both drugs effectively unlock immune genes that should stay quiet, producing the same kind of overactive, self-targeting T cells seen in spontaneous lupus.
Gut Bacteria and Immune Balance
People with lupus consistently show an altered gut microbiome compared to healthy individuals. The ratio of two major bacterial groups, Firmicutes and Bacteroidetes, is lower in lupus patients. Beneficial bacteria like Faecalibacterium (which produces anti-inflammatory compounds) are reduced, while potentially inflammatory species like Streptococcus are elevated.
One bacterium in particular, Ruminococcus gnavus, has drawn attention. Antibodies against R. gnavus in the blood correlate with both disease activity scores and anti-DNA antibody levels, two key markers of lupus severity. The gut barrier in lupus patients also tends to be more permeable, allowing bacteria and their byproducts to leak into the bloodstream and provoke systemic inflammation. Whether gut changes are a cause of lupus or a consequence remains an active question, but the relationship appears to be a two-way street where gut imbalances and immune dysfunction reinforce each other.